The FDA announced on Aug. 17, 2020, that Mylan Institutional LLC voluntarily recalled Tranexamic Acid Injection due to a labeling mix-up hazard. The agency stated the recall involves potential cross-contamination of drug identities in cartons.
How to tell if you have it
- Brand: Mylan
- Product: Tranexamic Acid Injection, USP, 1000 mg/10 mL (100 mg/mL), 10 mL Single-Dose Vial (NDC 67457-197-00); 10 x 10 mL
- Lot codes: 191207, 191221, 191223, 200120
- Expiration dates: 11/2021, 12/2021
- Quantity: 1407 cartons
The hazard
The recall addresses a labeling mix-up where cartons labeled as Tranexamic Acid Injection may contain Amiodarone HCl Injection, and vice versa. The FDA classified this Class I hazard because incorrect administration could result in serious adverse health consequences.
Context
GovInfoNow's records show Mylan Institutional LLC has 10 other recalls on record since Jan. 23, 2015. Other recent recalls of similar products include Mylan Thiamine HCl Injection (May 3, 2021), Mylan Daptomycin Injection (July 7, 2020), and Mylan Aloprim Injection (May 5, 2020). Additional recent recalls of similar products include Mylan Mycophenolate Mofetil Injection (July 2, 2026), American Regent Levocarnitine Injection (April 16, 2026), and Amneal Magnesium Sulfate IV Bags (March 18, 2026).